📰 Cell Adhesion News
Page 2 - Cell Adhesion News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Adhesion. Real-time updates on events, politics, business and more.
November 22, 2022
In a recent study, researchers used proteomic analysis to identify novel immune cell phenotypes associated with severe coronavirus disease 2019 (COVID-19).
November 21, 2022
Researchers assessed the efficacy of CAR T-cells in the immunotherapy of colorectal cancer.
October 19, 2022
A new study published on the preprint server medRxiv* determines how endothelial activation and inflammation contribute to the formation of microclots in PASC.
October 5, 2022
In a new study, researchers developed a three-dimensional (3D) in vitro tissue model to assess the effects of SARS-CoV-2 on the vascular endothelial cells.
September 28, 2022
MIT Professor Richard Hynes, who studies cellular adhesion, has won the Albert Lasker Basic Medical Research Award along with Erkki Ruoslahti and Timothy Springer.
July 19, 2022
Cell, tissue, and organ structure is maintained by cell-cell adhesion molecules that connect opposing cells. Cadherins are a class of essential cell-cell adhesion molecules for tissue formation and integrity, and defects in cadherin function cause various diseases (e.g., cancer invasion).
June 24, 2022
In a recent study posted to the bioRxiv* pre-print server, researchers investigated the blood levels of neurotoxic metabolites in patients with mild coronavirus disease 2019 (COVID-19).
June 21, 2022
Silk has been cultivated for centuries by domesticated silkworms, but it has been difficult to commercially produce spider silk in bulk due to their cannibalistic tendencies.
June 1, 2022
A new research paper was published in Aging (Aging-US) on the cover of Volume 14, Issue 10, entitled, "Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)."
May 12, 2022
One of the most common causes of disability or death in newborns is a lack of oxygen or blood flow in the brain during labor or delivery.